Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base edito...
Use this information to figure out if this company is an ideal customer for you.
866.803.9204
26 Landsdowne Street
Cambridge, 02142
1,001 - 5,000 Employees
$1M - $5M
linkedin.com/company/beamtx
The most common Beam Therapeutics email format is [f][last] (ex. jdoe@beamtx.com), currently being used by 96% of Beam Therapeutics business email addresses. There are 14 email formats used by Beam Therapeutics.
Beam Therapeutics's CEO is Giuseppe Ciaramella
Beam Therapeutics's CTO is Faaps Manmohan Singh
Beam Therapeutics's CFO is Sravan Emany
Beam Therapeutics's HQ is located at 26 Landsdowne Street, Cambridge
Beam Therapeutics's phone number is 866.803.9204
Beam Therapeutics's official website is beamtx.com
Beam Therapeutics's revenue is $1M - $5M
Beam Therapeutics has 1,001 - 5,000 employees
Beam Therapeutics is in the industry of: Biotechnology
